(…) In January, recognizing the worsening situation, the health ministry announced a package of rules for the industry. Organizations using stem cells must register their research and clinical activities, the source of the stem cells and ethical procedures. The ministry asked local health authorities to halt any unapproved clinical use of stem cells in their regions. And it called for a nationwide moratorium on new clinical trials for stem-cell therapies, adding that patients in existing clinical trials should not be charged.
So far, however, the ministry’s clampdown has proved ineffective. According to a Ministry of Health spokesman, not one clinic
Image via Wikipedia
A process that prompts a single gene to generate millions of supercharged stem cells, which can then turn into any kind of cell a body needs to repair itself, has been patented at the University of Central Florida.
Stem cells have long been regarded as a holy grail of sorts in the medical world, because they hold so much potential for treating and perhaps curing some of the most challenging diseases in our time, such as Alzheimer’s, Parkinson’s and diabetes.
But a limited supply of stem cells and ethical issues associated with cells from embryonic donors have stalled
“You can make liver. You can make pancreas. You can make bone. Therefore you can make neuro cells. You can make heart cells,” said Dr. Robert Carpenter
Yes, he said make a liver make a heart. From what? Stem cells from your teeth.
“We recently discovered that adult stem cells that don’t have the controversy related to it like embryonic cells have the ability to regenerate and treat a number of illnesses and injuries,” Carpenter said.
Stem cells are being studied to affect other disease like diabetes, kidney problems; liver problems even Parkinson’s disease. It’s in human clinical trials, and
Using two distinct methods, Whitehead Institute researchers have successfully and consistently manipulated targeted genes in both human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells (adult cells that have been reprogrammed to an embryonic stem cell-like state).
In one case, scientists employed proteins known as zinc finger nucleases (ZFNs) to change a single base pair in the genome, allowing them either to insert or remove mutations known to cause early-onset Parkinson’s disease (PD). The second method relies on proteins called transcription activator like effector nucleases (TALENs) capable of altering specific genes with similar efficiency and precision as ZFNs.
The flattening of the world’s economy has spawned a new trend in the local medical-tourism industry: Foreigners are starting to come to the Philippines because of the country’s ever-growing availability of cheap but reliable regenerative or stem-cell treatments.
Dr. Samuel Bernal, consultant on regenerative medicine for the Medical City, said some hospitals in the Philippines are starting to gain vigor in stem-cell treatments. Patients treated last year reached over 100 in number.
“Ours [Philippines] is cheaper compared to other developed and developing nations,” Bernal told the BusinessMirror in a phone interview on Monday after a briefing with the media on “Bioregenerative